NCT06510062 - Comparative Evaluation of Sustained Acoustic Medicine Device on Circulation | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 22, 2024

Primary Completion Date

September 30, 2024

Study Completion Date

December 31, 2024

Conditions

Measurement of Circulation on Anatomical Locations of the Body

Interventions

DEVICE

Sustained Acoustic Medicine

The SAM device emits continuous ultrasound at 3 megahertz (MHz) frequency and 0.132 watts/cm2 intensity delivering 18,720 Joules of ultrasound per 4 hour treatment.

DEVICE

Sustained Acoustic Medicine

The SAM device emits continuous ultrasound at 3 megahertz (MHz) frequency and 0.132 watts/cm2 intensity delivering 18,720 Joules of ultrasound per 4 hour treatment.

DEVICE

Sustained Acoustic Medicine

The SAM device emits continuous ultrasound at 3 megahertz (MHz) frequency and 0.132 watts/cm2 intensity delivering 18,720 Joules of ultrasound per 4 hour treatment.

DEVICE

Sustained Acoustic Medicine

The SAM device emits continuous ultrasound at 3 megahertz (MHz) frequency and 0.132 watts/cm2 intensity delivering 18,720 Joules of ultrasound per 4 hour treatment.

DRUG

2.5% Diclofenac Patches

Topical pain relief gel worn via SAM patch.

Trial Locations (1)

06611

ZetrOZ Systems LLC, Trumbull

All Listed Sponsors

lead

ZetrOZ, Inc.

INDUSTRY